Haemonetics Corp

HAE

Company Profile

  • Business description

    Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

  • Contact

    125 Summer Street
    BostonMA02110
    USA

    T: +1 781 848-7100

    E: [email protected]

    https://www.haemonetics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 March 2027

    Employees

    3,009

Stocks News & Analysis

stocks

ASX healthcare share undervalued post earnings

Short term headwinds mask long term value opportunity.
stocks

ASX energy share sees 363% increase in dividend

Geopolitical tensions drive strong profit and dividends for oil refiner.
stocks

Wide moat share remains cheap despite rising costs

Higher costs weigh on profits but stronger sales trends support long term outlook.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,338.8054.50-0.58%
CAC 408,476.0436.840.44%
DAX 4026,318.4752.330.20%
Dow JONES (US)53,577.40160.240.30%
FTSE 10010,873.3912.77-0.12%
HKSE25,652.97141.870.56%
NASDAQ26,151.30171.110.66%
Nikkei 22566,262.16405.730.62%
NZX 50 Index14,013.2120.490.15%
S&P 5007,677.2824.420.32%
S&P/ASX 2009,127.8055.90-0.61%
SSE Composite Index3,912.5223.080.59%

Market Movers